All events

Conference

Fierce Biotech Summit

A strategic event examining drug development, clinical trial tech, and biotech dealmaking across the life sciences ecosystem.

When
September, Late September
Where
Boston, USAView on Google Maps
Format
In person
Organiser
Questex
Region
North America
Scale
About 800 attendees
Founded
2022

The Signal

Run by Questex, the event focuses on the intersection of drug discovery, digital clinical trials, and capital allocation. Executives from pharma, biotech, and research organizations gather to address clinical development bottlenecks. Key topics include using artificial intelligence in drug design, decentralizing trials, and navigating FDA regulatory changes. For technology operators, it provides a direct window into the product needs of pharmaceutical partners.

What to expect

  • Discussions on clinical trial design and patient recruitment tech
  • Analysis of pharmaceutical mergers and acquisitions activity
  • Updates on regulatory pathways for novel therapies and biomarkers

Who is in the room

Biotech executives, pharmaceutical drug development leads, clinical trial tech vendors, and life science venture capitalists.

Background

Launched by the editors of Fierce Biotech to bridge the gap between business strategy and scientific research. It has become a key autumn fixture for East Coast biotechnology leaders.

Official event site

Related events

Running this event, or spotted something out of date?

Related reading